Position history for BAKER BROS. ADVISORS LP's holdings in XENON PHARMACEUTICALS INC
BAKER BROS. ADVISORS LP holds 370,208 shares of XENE (XENON PHARMACEUTICALS INC), worth $21.5M as of 2026-Q1. XENE represents 0.1% of BAKER BROS. ADVISORS LP's portfolio.
Current Value
$21.5M
Current Shares
370,208
Total Value Change
-$17.2M
Total Shares Change
-623,471
Other major holders of XENE: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Unchanged |
| 370,208 |
0.0% |
| $21.5M |
| 0.1% |
| $43.79 |
0 |
| 2025-Q4 | Unchanged | 370,208 | 0.0% | $16.6M | 0.1% | $44.12 | 0 |
| 2025-Q3 | Unchanged | 370,208 | 0.0% | $14.9M | 0.1% | $39.06 | 0 |
| 2025-Q2 | Increased | 370,208 | +6.6% | $11.6M | 0.1% | $32.40 | 36 |
| 2025-Q1 | Decreased | 347,408 | -65.0% | $11.7M | 0.1% | $34.26 | 0 |
| 2024-Q4 | Unchanged | 993,679 | 0.0% | $39M | 0.4% | $38.53 | 0 |
| 2024-Q3 | Unchanged | 993,679 | 0.0% | $39.1M | 0.4% | $38.65 | 0 |
| 2024-Q2 | Unchanged | 993,679 | 0.0% | $38.7M | 0.5% | $38.99 | 0 |